Cooperative Function of LL-37 and HNP1 Protects Mammalian Cell Membranes from Lysis.
Drab. Ewa E; Sugihara. Kaori K
Key Findings
- LL‑37 and HNP1 together boost antibacterial killing.
- The peptide pair reduces damage to mammalian cell membranes, acting protectively.
- Their effect flips from membrane‑destructive to membrane‑protective depending on whether the target is a pathogen or host cell.
Practical Outcomes
- If you’re exploring LL‑37 as a health‑boosting peptide, combining it with HNP1 might lower the risk of cell toxicity. However, exact dosing and delivery methods aren’t defined yet, so more research is needed before applying this in a DIY protocol.
Summary
The study shows that two natural immune peptides, LL‑37 and HNP1, work together not only to kill bacteria but also to shield our own cells from damage. When both are present, they can change from breaking membranes (against microbes) to protecting them (against self‑damage). This suggests a built‑in safety switch that could matter if you ever use these peptides as supplements or therapies.
Abstract
LL-37, cleaved from human cathelicidin, and human neutrophil peptide-1 (HNP1) from the defensin family are antimicrobial peptides that are occasionally co-released from neutrophils, which synergistically kill bacteria. We report that this couple presents another type of cooperativity against host eukaryotic cells, in which they antagonistically minimize cytotoxicity by protecting membranes from lysis. Our results describe the potential of the LL-37/HNP1 cooperativity that switches from membrane-destructive to membrane-protective functions, depending on whether the target is an enemy or a host.
Study Information
pubmed
2020
2020-11-04T00:00:00.000Z
10.1016/j.bpj.2020.10.031
18
91